- $98.13m
- $152.41m
- $78.23m
OptiNose Inc expected to post a loss of 74 cents a share - Earnings Preview
Brief: OptiNose Q4 Income From Operations USD 354 Thousand
U.S. RESEARCH ROUNDUP-Darden Restaurants, Nike, Optinose
U.S. STOCKS ON THE MOVE-Accenture, Nike, FedEx
U.S. STOCKS ON THE MOVE-KKR, Micron Technology, Eli Lilly
Optinose surges on Paratek Pharma's buyout deal for up to $330 million
U.S. STOCKS ON THE MOVE-Five Below, QXO, PDD Holdings
U.S. STOCKS ON THE MOVE-Accenture, Coty, Optinose
Optinose rises on Paratek Pharma's acquisition deal of up to $330 million
Brief: Paratek Pharmaceuticals To Acquire Optinose for Up To $330 Million
OptiNose Inc expected to post a loss of 72 cents a share - Earnings Preview
OptiNose Inc expected to post a loss of 72 cents a share - Earnings Preview
OptiNose Inc expected to post a loss of 72 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Super Micro, Dollar Tree, Carvana
U.S. STOCKS ON THE MOVE-Adobe, US Steel, Rivian Automotive
U.S. STOCKS ON THE MOVE-U.S. Steel, PulteGroup, liquor stocks
H.C. Wainwright raises OptiNose PT on nasal spray prospects
OptiNose Inc reports results for the quarter ended September 30 - Earnings Summary
OptiNose Inc expected to post a loss of 5 cents a share - Earnings Preview